T0	Participants 26 56	tuberculosis in HIV infection:
T1	Participants 194 268	tuberculin skin test-positive and negative individuals with HIV infection.
T2	Participants 331 408	Seven trials from Mexico, Haiti, the United States, Zambia, Uganda and Kenya.
T3	Participants 418 518	Individuals free from tuberculosis, 2367 persons in the intervention and 2162 in the control groups.
T4	Participants 712 758	isoniazid prophylaxis in HIV-infected persons.
T5	Participants 1778 1805	persons with HIV infection.
T6	Participants 1820 1872	restricted to tuberculin skin test-positive persons.